volume::125mL×4
| Form::Liquid | Bacteria Detection::Negative |
| Fungi Detection::Negative | Mycoplasma Detection::Negative |
| Endotoxin Content:: | pH::7.4-7.8 |
| Components::RPMI-1640 [PM150110]+10 μg/mL Insulin [PB180432]+10% Nutrient+1% Supplement | Green Features::Sustainable packaging |
| Valid Period::6 months | Storage Condition::This product can be stored at 2-8℃ for 6 months with shading light. |
| Matters Need Attention::1. This product is for research use only. 2. This product is sterilized by 0.1 μm filtration. 3. It is necessary to pay attention to the aseptic operation and avoid the contamination during the culture. 4. It is not suitable for long time storage at room temperature. 5. This product is a ready-to-use medium. If there is no special need, don't add serum, penicillin and streptomycin. It can be used directly. | System Certification::GMP Production and Quality System The company complies with cGMP requirements, holds the NMPA medical device registration certificate, and is certified under ISO 13485 and ISO 9001 standards. Among its products, the company's T-47D Cell Complete Medium complies with ISO 9001. |
| biogegep7 | biogegep17 |
| biogegep8 | biogegep18 |
| biogegep9 | biogegep19 |
| biogegep10 | biogegep20 |
Title: LCAL4–FUS cooperation switches on MMP13 and drives osteolytic bone metastasis in breast cancer
Journal: ONCOGENE (2026)
IF: 9.1
DOI: 10.1038/s41388-026-03848-z
Article URL: https://www.nature.com/articles/s41388-026-03848-z
Product Cited: RAW 264.7 Cell Complete Medium, MDA-MB-231 (L15) Cell Complete Medium, MDA-MB-361 (L15) Cell Complete Medium, MCF 10A Cell Complete Medium, E0771 Cell Complete Medium, BT-549 Cell Complete Medium, 293T Cell Complete Medium, T-47D Cell Complete Medium, BT-474 Cell Complete Medium, SUM159PT Cell Complete Medium, MCF7 Cell Complete Medium
Title: EBF3 transcriptionally activates ACADL to block the Hippo/YAP signaling pathway and inhibits breast cancer progression
Journal: PATHOLOGY RESEARCH AND PRACTICE (2025)
IF: 3.2
DOI: 10.1016/j.prp.2025.156299
Article URL: https://www.sciencedirect.com/science/article/pii/S0344033825004923
Product Cited: ZR-75-1 Cells Line, T-47D Cell Complete Medium, MCF 10A Cell Complete Medium, MCF7 Cells Line, MCF 10A Cells Line, MCF7 Cell Complete Medium, T-47D Cells Line, MDA-MB-231 Cell Complete Medium, MDA-MB-231 Cells Line, ZR-75-1 Cell Complete Medium
Title: Prediction of cancer cell line-specific synergistic drug combinations based on multi-omics data
Journal: PeerJ (2025)
IF: 2.3
DOI: 10.7717/peerj.19078
Article URL: https://peerj.com/articles/19078/
Product Cited: T-47D Cells Line, T-47D Cell Complete Medium
Title: Integrative analysis based on the cell cycle-related genes identifies TPX2 as a novel prognostic biomarker associated with tumor immunity in breast cancer
Journal: Aging-US (2024)
IF: 3.9
DOI: 10.18632/aging.205752
Article URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11087105/
Product Cited: MCF7 [MCF-7] Cell Complete Medium, MDA-MB-453 Cell Complete Medium, MCF 10A Cell Complete Medium, MDA-MB-231/GFP (L15) Cell Complete Medium, T-47D Cell Complete Medium, BT-474 [BT474] Cell Complete Medium, RPMI-1640 Complete Medium (10)
Title: The synergistic effect of epigallocatechin-3-gallate and quercetin co-loaded hydrogel beads on inflammatory bowel disease
Journal: Food & Function (2023)
IF: 6.1
DOI: 10.1039/D2FO04029H
Article URL: https://pubs.rsc.org/en/content/articlelanding/2023/fo/d2fo04029h
Product Cited:, T-47D Cells Complete Medium
Title: Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling
Journal: Cells (2019)
IF: 6
DOI: 10.3390/cells8080892
Article URL: https://www.mdpi.com/2073-4409/8/8/892/htm
Product Cited:,, BT-549 Cells Complete Medium, MCF-7/DDP Cells Complete Medium, T-47D Cells Complete Medium